Williams-Sonoma (NYSE:WSM) reported financial results for the fourth quarter and fiscal year ended February 1, 2026, revealing a resilient top line tempered by significant macroeconomic headwinds.
TOYO (NASDAQ:TOYO) reported preliminary, unaudited financial results for the fiscal year ended December 31, 2025, highlighting a transformative year of global capacity expansion and robust shipment volumes.
Protagonist Therapeutics (NASDAQ:PTGX) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 and older weighing at least 40 kg.
The Progressive Corporation (NYSE:PGR) released its monthly financial results for February 2026, demonstrating continued growth in its customer base and sustained underwriting profitability.
Dogwood Therapeutics (NASDAQ:DWTX) reported its fourth-quarter and full-year 2025 financial results, highlighting a pivot toward late-stage clinical development for its lead analgesic candidate, Halneuron®.
Lifeward (NASDAQ:LFWD) reported its fourth-quarter and full-year 2025 financial results on Wednesday, March 18, 2026, highlighting a year of significant structural changes and improved reimbursement access.
Cingulate (NASDAQ:CING) announced its fourth-quarter and full-year 2025 financial results alongside several critical regulatory milestones on March 18, 2026.
InspireMD (NASDAQ:NSPR) reported a significant acceleration in its commercial operations for the fourth quarter of 2025, fueled by the successful U.S. market introduction of its CGuard Prime Carotid Stent System.
Kanzhun (NASDAQ:BZ), the leading online recruitment platform in China, reported a significant leap in profitability for the 2025 fiscal year, driven by steady revenue growth and a dramatic improvement in operating efficiency.
Jabil (NYSE:JBL) today reported preliminary, unaudited financial results for its second quarter of fiscal year 2026, delivering a performance that exceeded internal guidance and Wall Street consensus.
Spire Global (NYSE:SPIR) reported fourth-quarter 2025 financial results characterized by a dramatic reduction in net loss and strong organic growth within its core data and space services segments.
Macy’s (NYSE:M) reported fourth-quarter 2025 financial results that cleared the high end of its previous guidance, driven by robust luxury demand and an accelerating turnaround within its core department store fleet.
